Prabhudas Lilladher has reaffirmed a BUY rating for Sun Pharmaceutical Industries with a revised target price of Rs 2,275.

Domestic brokerage Bajaj Broking has issued a Buy call on Sun Pharmaceutical Industries, setting a target price of Rs 2,180 in its High Conviction Margin Trading Funding pick dated July 28, 2026.

On Monday, domestic stock markets experienced a severe drop as the S&P BSE Sensex fell over 1,100 points in morning trade, eventually sliding 1,300 points to 78,420, while the NSE Nifty50 decli

Prabhudas Lilladher reaffirms its "Buy" stance on Sun Pharmaceutical Industries Ltd. (SUNP), revising the target price to Rs.2,100 from Rs.1,885.

ITC, Axis Bank, Asian Paints, TCS and Sun Pharmaceuticals were offering support to markets in today’s trading session.

Market expert Kushal Gupta has suggested five BUY Calls and no SELL Call for today’s trading session.